The biotech industry is well-positioned for steady growth, owing to rapid advancements in drug developments and the growing demand to treat chronic diseases. Given the industry’s solid long-term growth prospects and ability to navigate the uncertain macroeconomic conditions because of inelastic demand, quality biotech stocks Alkermes plc (ALKS), Amgen Inc. (AMGN) and Incyte Corporation (INCY) could be wise additions to your portfolio now.
Before delving deeper into the fundamentals of these stocks, let’s discuss what’s happening in the biotech industry.
